RE:RE:RE:RE:RE:RE:India rocks... here's why...canyousayiii wrote: Overroad, back in the Fall, KNR was pursuing a 20,000 monthly capacity to focus primarily on large orders and on Canada...even thought the first exclusive distributor was USSC for the North American continent. India was NOT in the picture because tariffs were seen as making it cost prohibitive. (FYI for Wilander, the standard of living and the earning power of an average worker in India is much, much lower than here.) Fast forward, KNR was looking for a Canadian source for the reagent to reduce the cost of cartridges, as it was originally coming from the US. They said they found it. OES had manufacturing capacity of 10,000, Danby was to get it up 20,000...but then they split how they were going to put it together. So, fill us in on the India manufacturing of the units and the reagents. I heard of nothing from KNR about it. And fill us in whether they have therefore reduced the manufacturing costs for everyone and whether the price tag for a capital purchase is still USD $12K...but we do know they are offering a full service for $200 per month. Filling us in on facts that were not publicly disclosed would be helpful and appreciated. Guessing, not so much, because you have no clue.
yes you are corrext, india WAS NOT in the picture due to tarrifs. tarrifs that are removed when a certain percentage of a product is manufactured locally. so there is a scenario where bioclouds can be made cheaper. my guess, konyrol went with the "canadian manufactured" angle to appease certain government entities here. seems logical that paul would do the same in india to avoid tarrifs.